Yitao Ding

机构：Shandong University, Nanjing General Hospital of Nanjing Military Command, Shandong Provincial Hospital, Ministry of Education, Shougang (China), Shandong First Medical University · ORCID：0000-0002-6552-0838

发表论文 52 篇 · 总被引 2585 次 · h-index 27

代表论文

• Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway (2018 · EBioMedicine · 被引 245)
• Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells (2016 · Cell Death and Disease · 被引 187)
• Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro (2016 · Journal of Experimental & Clinical Cancer Research · 被引 157)
• Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis (2017 · Oncotarget · 被引 120)
• Interleukin‐10 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis (2017 · Hepatology Research · 被引 110)
• Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma (2017 · Scientific Reports · 被引 84)